Rafael Gómez Fernández
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Rafael Gómez Fernández has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Beatriz Zarauza Santos1 shared publication
- Beatriz Zarauza-Santos
Department of Oral and Maxillofacial Surgery, Hospital Universitario Río Hortega, Calle Dulzaina 2, 47012 Valladolid, Spain
1 shared publication - Belén Burgos Vico
Servicio de Cirugía Maxilofacial, Hospital Universitario Río Hortega, Valladolid, España
1 shared publication - Claudia García Sierra1 shared publication
- Diego López Díaz1 shared publication
- Elena Fernández Fernández1 shared publication
Latest Publications
- Open Access
- 21 July 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (14) , 2276
Plasma Fibrinogen at Recurrence as a Prognostic Blood Biomarker in Oral Cavity Squamous Cell Carcinoma
Background: Preoperative inflammatory biomarkers, particularly the neutrophil-to-lymphocyte ratio (NLR), are established prognostic markers in oral cavity squamous cell carcinoma (OCSCC), yet their relevance at the biologically distinct timepoint of disease recurrence is unknown. We evaluated blood biomarkers measured at recurrence. Methods: From a retrospective cohort of 168 surgically treated OCSCC patients, 70 (41.7%) developed recurrence (49 local, 21 distant). NLR, lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), plasma fibrinogen, albumin and the prognostic nutritional index (PNI) at relapse were analysed against 5-year overall survival; multivariate logistic regression was adjusted for age and recurrence type. Results: Forty-nine of 70 patients (70.0%) died within 5 years. Fibrinogen was higher in deceased patients (median 595 vs. 464 mg/dL; p = 0.007) and was the only biomarker to retain independent significance (OR 1.005 per mg/dL; 95% CI 1.000–1.010; p = 0.038); in contrast, NLR lost significance (p = 0.156). LMR was significant univariately (p = 0.036); PLR, albumin and PNI were not. Conclusions: In this exploratory single-centre cohort, higher plasma fibrinogen at recurrence was independently associated with 5-year mortality, whereas inflammatory ratios were not. These hypothesis-generating findings warrant validation in larger, multicentre cohorts.
- 21 July 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (14) , 2276
Open AccessPlasma Fibrinogen at Recurrence as a Prognostic Blood Biomarker in Oral Cavity Squamous Cell Carcinoma
Background: Preoperative inflammatory biomarkers, particularly the neutrophil-to-lymphocyte ratio (NLR), are established prognostic markers in oral cavity squamous cell carcinoma (OCSCC), yet their relevance at the biologically distinct timepoint of disease recurrence is unknown. We evaluated blood biomarkers measured at recurrence. Methods: From a retrospective cohort of 168 surgically treated OCSCC patients, 70 (41.7%) developed recurrence (49 local, 21 distant). NLR, lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), plasma fibrinogen, albumin and the prognostic nutritional index (PNI) at relapse were analysed against 5-year overall survival; multivariate logistic regression was adjusted for age and recurrence type. Results: Forty-nine of 70 patients (70.0%) died within 5 years. Fibrinogen was higher in deceased patients (median 595 vs. 464 mg/dL; p = 0.007) and was the only biomarker to retain independent significance (OR 1.005 per mg/dL; 95% CI 1.000–1.010; p = 0.038); in contrast, NLR lost significance (p = 0.156). LMR was significant univariately (p = 0.036); PLR, albumin and PNI were not. Conclusions: In this exploratory single-centre cohort, higher plasma fibrinogen at recurrence was independently associated with 5-year mortality, whereas inflammatory ratios were not. These hypothesis-generating findings warrant validation in larger, multicentre cohorts.